US$ 24.66
glp 1 agonists New GLP-1 Guidelines for Type 2 Diabetes in 2025 Can one drug do it
Description
The magnitude of the benefits of GLP-1RA and SGLT-2 inhibitors on MACE are similar, ranging from 12 to 14% reduction of risk, but only GLP-1RA may reduce the risk of stroke

WHO Guidelines

The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.

These medications also delay gastric emptying through neural mechanisms, increasing the risk for perioperative aspiration during anaesthesia and sedation

GLP-Pro pairs pasteurized Akkermansia, ButyraGen and resilient Bacillus spores to nourish L-cellsthe gut messengers that naturally release GLP-1while reinforcing the intestinal barrier and short-chain fatty-acid output for balanced appetite cues, comfortable digestion and everyday metabolic wellness.*
